Stay updated on Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial

Sign up to get notified when there's something new on the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New revision v3.3.2 appears in the Record History, superseding v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:19:51.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added to the page history and Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:32:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding notice banner was removed from the page, removing the lapse-in-funding message previously shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:52:50.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The Record History shows updates to the ROSE2 trial across multiple versions, including recruitment and study status changes in 2022 and a 2024 update that adds/adjusts Study Status, Outcome Measures, and related sections, along with updates to Contacts/Locations and Study Design.
    Difference
    0.1%
    Check dated 2025-11-03T01:17:38.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    13%
    Check dated 2025-10-05T10:12:54.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:16:00.000Z thumbnail image

Stay in the know with updates to Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page.